PURPOSE: To determine the efficacy and safety of ultrasound-guided percutaneous @entity1068 ablation for the management of benign thyroid cysts. STUDY DESIGN: In this prospective study, 40 @entity1 with fine-needle aspiration cytology-proven benign thyroid cysts underwent @entity167 ablation. Sonographically, 24 nodules were predominantly cystic (simple cysts), and 16 showed both solid and cystic elements ( @entity45 ). The cyst fluid was aspirated, and an amount of sterile 95% @entity1068 equivalent to approximately 50% of the aspirated fluid was injected. Initially, a 20-gauge needle on a 20 ml syringe was used. Later, a three-way cannula was used in which one port was used for aspiration of the cyst fluid and the other for injection of the alcohol. RESULTS: The pretreatment volume of the cysts was 5.8-18.5 ml (mean (SD) 12.26 (3.6)). Cyst volume after treatment was 0-8 ml (mean (SD) 3.73 (2.8)). Ten cysts had disappeared completely after treatment. Cosmetic symptoms disappeared in 90% of the @entity1 . Twenty-four @entity1 complained of a @entity809 at the injection site. The use of the three-way cannula helped to decrease the procedure time by decreasing the chances of needle displacement. CONCLUSION: Ultrasound-guided @entity1068 ablation is a safe, highly effective, relatively rapid treatment modality that is both @entity1 and surgeon friendly and should be considered as the treatment of choice for benign cystic thyroid nodules.

Non-surgical management of benign thyroid cysts: use of ultrasound-guided XXXX ablation.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity167 :: ('CHEBI:16236', 'Chemical') :: ['alcohol'] @entity809 :: ('MESH:D010292', 'Disease') :: ['local burning sensation'] @entity45 :: ('MESH:D010181', 'Disease') :: ['complex cysts'] @entity1068 :: ('MESH:D000431', 'Chemical') :: ['ethanol']
@entity1068 :: (MESH:D000431,Chemical) :: ['ethanol']
